2165 SPRING STREET, LONG BEACH, CA
Reports Full Year and Fourth Quarter 2025 Financial Results
Investor Presentation
Reports Third Quarter 2025 Financial Results
Appoints Philippe Schaison, PharmaD, to Board of Directors
Amended material disclosure
Names Pedro Malha President and Chief Executive Officer
News, Securities Holder Rights or Indentures
Financial Results, Press Release
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Post-Effective Amendment to Registration Statement
Submission Upload